Newsmeme!
Discover News you didn't know existed
Researchers dusted wild deer mice with fluorescent pink, blue, green, yellow and orange talcum powders to show which rodents most often fought or mated with others and thus were most likely to spread deadly hantavirus. The study identified bigger, older mice as the culprits.
Three-hundred years ago Britain was markedly different from the country now facing lowest base rates since the bank was formed
In 1902, faced with an outbreak of smallpox, the City of Cambridge, Massachusetts, adopted a mandatory vaccination law. Challenged by a Mr. Henning Jacobson as...
MARIETTA, Pa. - GlaxoSmithKline P.L.C. today announced a new $300 million Lancaster County vaccine plant that it said would be the hub for a big push into vaccine production in the United States.
After pandemics caused a mass die-off in the New World, farmland turned to forest and temperatures dropped
Remember your grandparents' conversations about the good old days? They weren't always so good, you know. Without antibiotics, infections could be deadly and vaccinations weren't widely used for contagious diseases.
University of Utah researchers dusted wild deer mice with fluorescent pink, blue, green, yellow and orange talcum powders to show which rodents most often fought or mated with others and thus were most likely to spread deadly hantavirus. The study identified bigger, older mice as the culprits.
Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that the Company has completed a single and multi-dose Phase I study of CMX001 in healthy volunteers. This study supports the further development of the drug for multiple dsDNA infections. The Company has initiated the first Phase II multi-dose clinical trial in patients.
Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, has announced that the Company has completed a single and multi-dose Phase I study of CMX001 in healthy volunteers.
Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced recently that the Company has completed a single and multi-dose Phase I study of CMX001 in healthy volunteers.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |